GLP-1 medications have become one of the most talked-about developments in metabolic health and weight management. Medications such as semaglutide and tirzepatide have changed the way healthcare professionals approach obesity, blood sugar regulation, and certain weight-related health conditions.
But with so much information circulating online, it can be difficult to separate the science from the hype.
Are GLP-1 medications safe? Who is a good candidate? Do they cause muscle loss? What happens when you stop taking them? And why is medical supervision so important?
At Rediscover Health, we believe weight management should be about more than a number on the scale. It should consider metabolic health, nutrition, hormones, sleep, muscle mass, medical history, and long-term wellness.
Let's take a closer look.
What Are GLP-1 Medications?
GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in the digestive system after eating.
This hormone helps regulate several important processes, including:
-
Appetite and feelings of fullness
-
Insulin release when blood sugar rises
-
Glucagon secretion, which helps regulate blood glucose
-
The rate at which food leaves the stomach
GLP-1 medications work by activating receptors involved in these processes. They can help people feel full sooner, stay full longer, and experience reduced appetite.
Some medications act on the GLP-1 receptor alone, while others target more than one hormone pathway.
What Are the Most Common GLP-1 Medications?
Two medications frequently discussed in weight management are semaglutide and tirzepatide.
Semaglutide
Semaglutide is a GLP-1 receptor agonist. It is available under different brand names for different FDA-approved uses.
-
Wegovy is approved for certain patients for chronic weight management and other specific indications.
-
Ozempic is approved for type 2 diabetes and certain related risk-reduction indications.
-
Rybelsus is an oral formulation approved for type 2 diabetes.
Tirzepatide
Tirzepatide activates both GIP and GLP-1 receptors. GIP stands for glucose-dependent insulinotropic polypeptide.
-
Zepbound is approved for chronic weight management in eligible adults and for certain adults with obesity and moderate-to-severe obstructive sleep apnea.
-
Mounjaro is approved for type 2 diabetes.
Although these medications contain the same active ingredients across their respective brand families, their FDA-approved uses, formulations, and dosing instructions differ. They should not be treated as interchangeable products.
How Do GLP-1 Medications Work?
GLP-1 medications influence several systems involved in appetite and metabolism.
1. They help regulate appetite.
These medications act on areas of the brain involved in hunger and satiety. Many patients report feeling less hungry and having fewer persistent thoughts about food.
2. They slow stomach emptying.
Food may move more slowly from the stomach into the small intestine, particularly early in treatment. This can contribute to feeling full longer. The effect may change over time.
3. They support blood sugar regulation.
GLP-1 activity helps the pancreas release insulin in response to elevated blood glucose and reduces glucagon secretion when appropriate. This can improve blood sugar control.
4. They can support weight reduction.
By reducing appetite and food intake, these medications can help eligible patients achieve and maintain meaningful weight loss when combined with nutrition, physical activity, and ongoing care.
Who May Be a Candidate?
GLP-1 medications are not appropriate for everyone, and they are not intended simply for cosmetic weight loss.
For chronic weight management, common FDA-approved eligibility criteria for adults include:
-
A BMI of 30 or greater, indicating obesity; or
-
A BMI of 27 or greater with at least one weight-related health condition, such as high blood pressure, dyslipidemia, type 2 diabetes, or obstructive sleep apnea.
Eligibility depends on the specific medication, its approved indication, and the patient's overall clinical picture.
A healthcare professional should consider:
-
Current weight and weight history
-
Blood pressure and metabolic health
-
Blood glucose and A1c when appropriate
-
Current medications and supplements
-
Personal and family medical history
-
Gastrointestinal history
-
Gallbladder and pancreatic history
-
Pregnancy plans and reproductive considerations
-
Nutrition, activity, sleep, and mental health
-
Treatment goals, cost, and patient preferences
The goal is to determine whether potential benefits outweigh the risks—not simply whether a medication can produce weight loss.
What Are the Potential Benefits?
For appropriately selected patients, GLP-1 medications may offer benefits beyond weight reduction.
Depending on the specific medication and approved indication, benefits may include:
-
Improved blood glucose regulation
-
Reduced body weight
-
Improvements in blood pressure and triglyceride levels
-
Improvements in certain obesity-related conditions
-
Reduced cardiovascular risk in specific eligible patient populations
-
Improved obstructive sleep apnea in certain adults with obesity treated with tirzepatide
The degree of benefit varies from person to person. Results depend on the medication, dose, duration of treatment, health history, and accompanying lifestyle support.
What Are the Possible Side Effects and Risks?
Like all prescription medications, GLP-1 medications have potential side effects.
The most common include:
-
Nausea
-
Constipation
-
Diarrhea
-
Vomiting
-
Abdominal discomfort
-
Bloating
-
Reflux or indigestion
-
Decreased appetite
These symptoms are often more noticeable when starting treatment or increasing the dose.
More serious concerns can include:
-
Gallbladder disease, including gallstones
-
Pancreatitis
-
Dehydration and kidney injury, particularly with persistent vomiting or diarrhea
-
Severe gastrointestinal reactions
-
Low blood sugar when used with certain diabetes medications
-
Delayed stomach emptying, which may affect some patients and certain medical procedures
Seek prompt medical evaluation for severe or persistent abdominal pain, especially if it radiates to the back, repeated vomiting, inability to keep fluids down, or signs of dehydration.
Patients should tell their anesthesia and procedural teams if they take a GLP-1 medication because delayed stomach emptying may affect the risk of aspiration during general anesthesia or deep sedation. Medication management before a procedure should be individualized by the treating team.
Who Should Avoid or Use Extra Caution With These Medications?
Semaglutide and tirzepatide products have important contraindications and precautions.
They are contraindicated in people with:
-
A personal or family history of medullary thyroid carcinoma (MTC)
-
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
-
A serious hypersensitivity reaction to the medication or its ingredients
The thyroid warning is based on thyroid C-cell tumors observed in rodents. It is not known whether this risk applies to humans, but the contraindication remains part of the FDA-approved labeling.
These medications are generally not used during pregnancy for weight reduction. Patients who become pregnant should contact their prescribing clinician. Semaglutide should be discontinued at least two months before a planned pregnancy when used for weight reduction or cardiovascular risk reduction, according to its prescribing information.
A complete medication review and medical history are essential before treatment.
What About Muscle Loss?
This is an important concern that deserves more attention.
When a person loses weight, the weight reduction can include both fat mass and lean mass. Lean mass includes muscle and other nonfat tissues.
Rapid weight loss, inadequate protein intake, inactivity, and insufficient resistance exercise can increase the risk of losing too much muscle.
Why does this matter?
Muscle plays an important role in:
-
Blood glucose regulation
-
Metabolic health
-
Strength and mobility
-
Balance and fall prevention
-
Healthy aging
-
Physical independence
A responsible weight-management plan should focus on preserving muscle while reducing excess body fat.
Helpful strategies include:
-
Consuming adequate protein based on individual needs
-
Including resistance or strength training
-
Maintaining appropriate hydration
-
Eating enough overall calories and nutrients
-
Monitoring strength, energy, and physical function
-
Avoiding overly restrictive eating patterns
The goal should not be simply to lose weight quickly. It should be to improve body composition and long-term health.
Why Nutrition Matters During GLP-1 Treatment
Because appetite may decrease significantly, some people unintentionally eat too little or miss important nutrients.
This can contribute to fatigue, constipation, inadequate protein intake, and nutritional deficiencies.
A thoughtful nutrition plan should emphasize:
Protein: Include protein-rich foods throughout the day to support muscle maintenance and recovery.
Fiber: Gradually increase fiber from vegetables, fruits, legumes, nuts, seeds, and whole grains as tolerated. Fiber and adequate fluids can help support regular bowel movements.
Healthy fats: Include sources of unsaturated fats, such as olive oil, avocado, nuts, and seeds.
Micronutrients: Eat a variety of nutrient-dense foods to help meet vitamin and mineral needs.
Hydration: Drink adequate fluids, particularly if experiencing nausea, vomiting, diarrhea, or constipation.
Smaller meals, slower eating, and avoiding meals that are excessively large or high in fat may help some people manage gastrointestinal symptoms.
Nutrition needs should be individualized, especially for patients with diabetes, kidney disease, gastrointestinal conditions, or other medical concerns.
What Happens When You Stop Taking a GLP-1 Medication?
This is one of the most important questions to discuss before beginning treatment.
Obesity is a chronic, complex condition influenced by genetics, hormones, appetite regulation, environment, sleep, medications, and metabolic factors.
When a GLP-1 medication is discontinued, appetite may increase and some of the weight that was lost may return.
This does not mean the medication failed. It reflects the fact that the biological factors influencing weight often remain after treatment stops.
In clinical studies, many participants regained a substantial portion of lost weight after stopping semaglutide or tirzepatide.
Before starting treatment, patients should understand that weight management may require long-term care. A maintenance plan should be part of the conversation from the beginning.
Are Compounded GLP-1 Medications the Same as FDA-Approved Products?
This is an important safety distinction.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Compounding may be appropriate in certain circumstances when a patient's medical needs cannot be met by an FDA-approved medication. However, compounded medications should not automatically be considered equivalent to commercially manufactured products.
The FDA has reported concerns involving dosing errors, incorrect measurement, and adverse events associated with compounded injectable semaglutide and tirzepatide.
Patients should:
-
Obtain medication through a legitimate prescribing clinician.
-
Use a state-licensed pharmacy.
-
Confirm the exact medication, concentration, and instructions.
-
Understand how to measure and administer the prescribed dose.
-
Never use products sold as research chemicals or products that are not intended for human use.
Patients should also know that semaglutide salt forms, such as semaglutide sodium or semaglutide acetate, are not the same active ingredients used in FDA-approved semaglutide medications.
Why Medical Supervision Matters
GLP-1 medications are powerful tools, but they are not a complete weight-management plan.
Medical supervision helps ensure that treatment is appropriate, that side effects are addressed, and that progress is evaluated beyond the scale.
An individualized plan may include:
-
Reviewing medical history and current medications
-
Assessing metabolic risk factors
-
Reviewing appropriate laboratory testing
-
Evaluating nutrition and protein intake
-
Monitoring gastrointestinal symptoms and hydration
-
Supporting muscle preservation
-
Tracking weight and other meaningful health outcomes
-
Reassessing treatment effectiveness and tolerability
-
Planning for long-term maintenance
Not every patient needs the same laboratory tests, supplements, or treatment schedule. Testing and follow-up should be based on clinical history and individual risk.
A Whole-Person Approach to Weight Management
At Rediscover Health, we believe meaningful weight management involves looking at the whole picture.
Weight is influenced by much more than willpower or calorie intake. Metabolic health, insulin sensitivity, sleep quality, stress, medications, nutrition, hormones, muscle mass, and other health conditions can all play a role.
For some patients, GLP-1 medication may be an appropriate part of a broader plan. For others, different approaches may be more suitable.
Our philosophy is to look deeper, understand the factors influencing your health, and develop a plan that supports sustainable progress.
You deserve more than a number on the scale. You deserve a thoughtful approach to your health.
Interested in Learning Whether GLP-1 Treatment Is Right for You?
Rediscover Health offers personalized wellness and metabolic health consultations designed to help patients better understand their health goals and available options.
A consultation can help you explore your medical history, metabolic health, nutrition, and whether a medically supervised treatment approach may be appropriate.
Ready to take the next step?
Get started on GLPs today:
https://altroapp.com/rediscoverhealth
Book a consultation with Rediscover Health:
https://app.malla.co/join/rediscoverhealth
You can also explore practitioner-selected supplements through our Fullscript dispensary:
https://us.fullscript.com/s/rediscoverhealthsc/shop
Rediscover the Wisdom of the Body. Restore the Foundations of Health.
Frequently Asked Questions
Are GLP-1 medications only for people with diabetes?
No. Certain medications, including Wegovy and Zepbound, have FDA-approved indications for chronic weight management in eligible patients who do not necessarily have diabetes.
Do GLP-1 medications cause thyroid cancer?
Thyroid C-cell tumors have been observed in rodents exposed to these medications. Whether this occurs in humans is unknown. These medications are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Will I lose muscle while taking a GLP-1 medication?
Weight loss can include loss of lean mass. Adequate protein intake and resistance training can help support muscle preservation.
Can I take a GLP-1 medication if I have insulin resistance?
Some patients with insulin resistance may qualify for treatment depending on their overall health, BMI, comorbidities, and the specific medication's approved indication. A clinician should evaluate individual eligibility.
Do I have to take GLP-1 medications forever?
Not necessarily, but obesity is often a chronic condition. Weight regain is common after stopping treatment, so long-term maintenance should be discussed before treatment begins.
Can I take supplements while using a GLP-1 medication?
Some supplements may be appropriate, but others may worsen gastrointestinal symptoms or interact with medications. Review all supplements with your healthcare professional before starting them.
Medical Disclaimer: This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not replace individualized medical advice or establish a provider-patient relationship. Prescription medications should only be used under the direction of an appropriately licensed healthcare professional. Medication eligibility, benefits, risks, and monitoring requirements vary by individual. Always consult your healthcare professional before starting, stopping, or changing medication.